Introduction:
"Faecal Microbiota Transplantation" or "Stool Transplant" or "Poop Transplant", a fascinating medical treatment that captivates people's attention, particularly in understanding the importance of gut microbiome. While FMT has emerged as a prominent and effective therapy for treating refractory Clostridioides difficile infections (C. difficile infections), it is equally crucial for both health professionals and the public to be aware of its evolving long-term risks. This article endeavours to provide a detailed understanding of FMT and perplexing nature of the microbiome.
Understanding C. difficile infections:
Our gut is an ecosystem for trillions of diverse microbial communities. This rich diversity of microorganisms contributes to essential physiological processes within our body. Among these microbes, Clostridioides difficile (C. difficile) is a particular type of germ that can live in our gut without causing problems for many people. However, this spore-forming bacterium has the potential to disrupt our normal healthy microbial community. When we consume antibiotics to fight other infections (like cough), these medications unfortunately wipe out not only harmful microbes but also many beneficial bacteria in our gut city, leaving it vulnerable to opportunistic infections. The increase in growth of unhealthy microbes leads to dysbiosis which in turn results in weakened immune system, neurological disorders, gut disorders, and various microbial infections (most notably recurrent C. difficile infections). For many people mild C. difficile infections can be remedied with certain antibiotics. However, recurrent forms of the disease can be treated with FMT, that focuses on repairing and renovating the natural balance of our gut to fight off tenacious C. difficile infections.
What is FMT?
It is a medical administration of medically treated faecal solution (contains healthy microbiota) from donor into the intestinal tract of an infected person. It is essentially used to heal the recurrent infections caused by anaerobic bacteria Clostridium difficile. The injected healthy microbes from donor straightway alters the recipient's gut microbial community that accords health related advantages.
How FMT is done and Gut microbiome is altered?
Transfer of healthy microbes (processed stool sample) from the healthy donor to the dysbiotic colon can re-establish the balanced microbiome community. To achieve this re-establishment, FMT is administered through different approaches. The sample from the donor is thoroughly screened and medically prepared for transplantation is then delivered to recipient's digestive tract by one of the following ways:
Efficacy and Benefits of FMT:
FMT renders several advantages, specifically for people suffering from recurrent C. difficile infections. Here we summarize some of the key benefits of FMT:
Navigating the Potential Risks of FMT:
While no medical therapy is entirely risk-free, FMT also carries inherent side effects and long-term risks that people should be aware of before undergoing the procedure. Common and typical side effects like constipation, abdominal cramps, bloated stomach, loose stools, and flatulence are temporary. However, it is important that people are conscious of potential long-term risks associated with FMT:
1) Transmission of Pathogens: Despite careful medical screening of donor's sample in FMT, some pathogens are undetectable at the time of screening, and they may be transmitted to the recipient's gut, where they become active. Especially when accompanied by a weakened immune system, the transmitted pathogens can cause various infections like norovirus, drug resistant E. coli, etc.
2) Due to therapeutic procedures: Invasive procedures like colonoscopy, and endoscopy used during FMT, carry their own intrinsic risks such as perforation and bleeding.
FMT as Public Health Concern:
Beyond the patient-level risks, the following key aspects of FMT have become Public Health Concern.
On-going research parameters of FMT:
There are many FMT studies and researches are going on to expand the therapy's potency and implementations. Scientists and Doctors are actively investigating the following core aspects of FMT:
Mastering the understanding of unpredictable behaviour of microbes and pathogens in the gut is the ultimate challenge for the researchers. Future research studies on microbiome can help overcome these difficulties, and aid in inventing new delivery methods of FMT.
Conclusion:
On the global level, FMT is accepted as a successful therapy for the people with recurrent C. difficile infections. However, the therapy may not be suitable for patients who are on medications for other health conditions. Advanced scientific methods and computational tools, particularly in multi-omics studies can significantly increase the potency of microbial research, especially in human microbiome project. As mentioned in this article, FMT can carry long-term risks for some patients. Addressing these factors require a multifaceted approach, basically by increasing people's awareness on FMT's benefits and potential risks.
Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.